$654.11

+7.76 (+1.20%)

Weekly Expected Move ±4.3%

$599 $627 $655 $683 $711

NYSE · Consumer Cyclical · Department Stores · Tech Score Neutral · Power 59 · $10.2B mcap · 8M float · 1.94% daily turnover · Short 61% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE

58.3 / 100

NoneWeakNarrowWide

Primary source: Efficient Scale · ROIC: 44.8% · 5Y Avg: 67.3%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale ★

100

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. DDS has a Narrow competitive edge (58.3/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 44.8% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$468

Low

$468

Avg Target

$468

High

Based on 1 analyst since Aug 13, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 2Hold: 6Sell: 5Strong Sell: 0

Rating Summary

ConsensusHold

Avg Target$468.00

Analysts1

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-08-17	UBS	—	$465	$468	+3	-16.6%	$560.88
2026-05-06	UBS	—	$460	$465	+5	-16.8%	$559.12
2026-02-25	Telsey Advisory	—	$380	$650	+270	+7.1%	$606.67
2025-11-28	UBS	Mauricio Serna	$192	$460	+268	-31.3%	$669.49
2024-08-16	Telsey Advisory	Dana Telsey	Initiated	$380	—	+8.7%	$349.65
2024-08-15	CFRA	Zachary Warring	$500	$372	-128	+5.0%	$354.22
2024-05-16	UBS	Mauricio Serna	Initiated	$192	—	-55.8%	$434.45
2024-05-16	CFRA	Zachary Warring	Initiated	$500	—	+15.1%	$434.45

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. DDS receives an overall rating of A-. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5), P/B (2/5).

Rating Change History

Date	From	To
2026-08-25	A	A-
2026-08-14	A-	A
2026-08-10	A	A-
2026-08-03	A-	A
2026-07-25	A	A-
2026-07-22	A-	A
2026-05-14	B+	A-
2026-04-01	A-	B+
2026-03-05	A	A-
2026-02-26	A-	A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 67 Grade A+

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. DDS scores highest in Safety (100/100) and lowest in Growth (55/100). An overall grade of A+ places DDS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

8.94

Safe Zone

Piotroski F-Score

8/9

✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✗

Beneish M-Score

-2.39

Unlikely Manipulator

Ohlson O-Score

-9.62

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AA+

Score: 94.1/100

Trend: Deteriorating

Earnings Quality

100/100

OCF/NI: 1.06x

Accruals: -1.0%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. DDS scores 8.94, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. DDS scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. DDS's score of -2.39 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. DDS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. DDS receives an estimated rating of AA+ (score: 94.1/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). DDS's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

14.98x

PEG

0.74x

P/S

1.55x

P/B

4.81x

P/FCF

14.53x

P/OCF

12.73x

EV/EBITDA

8.59x

EV/Revenue

1.27x

EV/EBIT

9.95x

EV/FCF

13.26x

Earnings Yield

7.43%

FCF Yield

6.88%

Shareholder Yield

5.30%

Graham Number

$365.73

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 15.0x earnings, DDS trades at a reasonable valuation. An earnings yield of 7.4% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $365.73 per share, 79% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.811

NI / EBT

Interest Burden

1.000

EBT / EBIT

EBIT Margin

0.127

EBIT / Rev

Asset Turnover

1.775

Rev / Assets

Equity Multiplier

1.840

Assets / Equity

ROE

33.8%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. DDS's ROE of 33.8% is driven by Asset Turnover (1.775), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$1683.63

Price/Value

0.35x

Margin of Safety

65.06%

Premium

-65.06%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with DDS's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. DDS trades at a -65% premium to its adjusted intrinsic value of $1683.63, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 15.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$654.75

Median 1Y

$766.14

5th Pctile

$261.23

95th Pctile

$2247.40

Ann. Volatility

62.4%

Analyst Target

$468.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Alex Dillard President	$1,170,000	$283,788	$4,886,057
William Dillard, II Chief Executive Officer	$1,170,000	$283,788	$4,856,540
Drue Matheny Executive Vice President	$830,000	$131,388	$3,267,623
Mike Dillard Executive Vice President	$830,000	$131,388	$3,263,872
Phillip R. Watts Senior Vice President, Co-	$680,000	$89,296	$3,166,682
Chris B. Johnson Senior Vice President and Co-Principal Financial Officer	$680,000	$89,296	$2,066,377

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

29,100

+1.0% YoY

Revenue / Employee

—

Profit / Employee

—

SGA / Employee

—

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	41.3%	59.6%	62.6%	61.0%	58.2%	58.5%	52.7%	51.3%	45.4%	44.8%	40.3%	36.1%	33.3%	34.0%	30.9%	29.8%	29.0%	31.9%	33.9%	33.8%	33.77%
ROA	17.3%	27.2%	26.7%	28.3%	24.5%	27.1%	22.7%	24.1%	20.2%	21.8%	18.7%	18.4%	15.7%	17.0%	14.7%	15.7%	13.8%	16.2%	16.3%	18.4%	18.35%
ROIC	41.3%	66.0%	78.8%	65.1%	64.4%	66.8%	66.2%	61.1%	52.6%	57.1%	56.8%	46.2%	45.0%	46.0%	46.9%	46.4%	46.7%	44.7%	48.7%	44.8%	44.81%
ROCE	33.8%	49.6%	54.3%	54.4%	50.2%	46.4%	42.1%	39.7%	36.2%	36.2%	32.9%	29.5%	28.2%	28.5%	27.2%	27.4%	26.3%	26.9%	28.4%	29.4%	29.35%
Gross Margin	47.3%	41.9%	47.6%	41.8%	45.6%	38.7%	44.8%	40.0%	44.5%	37.6%	45.5%	38.6%	43.5%	36.0%	44.6%	34.6%	41.2%	33.9%	42.5%	40.6%	40.58%
Operating Margin	17.7%	18.7%	20.0%	13.7%	16.0%	15.0%	16.5%	11.0%	13.2%	13.2%	15.1%	6.6%	11.3%	11.7%	14.1%	6.1%	11.4%	10.4%	14.3%	8.1%	8.12%
Net Margin	13.0%	14.9%	15.3%	10.1%	11.9%	13.4%	12.5%	8.2%	10.3%	11.6%	11.4%	4.9%	8.6%	10.4%	10.6%	4.7%	8.7%	10.3%	15.8%	6.4%	6.38%
EBITDA Margin	20.9%	21.9%	23.2%	16.6%	18.9%	18.1%	19.2%	13.6%	16.2%	16.7%	18.0%	9.7%	14.4%	15.1%	17.0%	9.1%	14.3%	13.3%	23.3%	8.3%	8.32%
FCF Margin	15.7%	17.7%	17.7%	13.6%	14.2%	11.8%	10.6%	13.6%	10.3%	10.9%	10.4%	7.9%	10.0%	9.2%	9.4%	11.7%	11.7%	9.5%	11.4%	9.6%	9.57%
OCF Margin	17.1%	19.3%	19.4%	15.4%	15.9%	13.6%	12.4%	15.4%	12.2%	12.9%	12.4%	9.8%	11.7%	10.8%	10.7%	13.0%	13.1%	10.9%	12.8%	10.9%	10.93%
ROE 3Y Avg	snapshot only																				32.02%
ROE 5Y Avg	snapshot only																				41.57%
ROA 3Y Avg	snapshot only																				17.28%
ROIC 3Y Avg	snapshot only																				41.54%
ROIC Economic	snapshot only																				24.13%
Cash ROA	snapshot only																				19.23%
Cash ROIC	snapshot only																				54.76%
CROIC	snapshot only																				47.98%
NOPAT Margin	snapshot only																				8.94%
Pretax Margin	snapshot only																				12.75%
R&D / Revenue	snapshot only																				0.00%
SGA / Revenue	snapshot only																				27.13%
SBC / Revenue	snapshot only																				0.00%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	5.95	4.56	4.74	3.48	4.90	6.21	5.15	5.75	5.56	7.75	8.86	8.05	8.55	12.00	9.53	12.25	15.45	16.61	13.42	13.45	14.982
P/S Ratio	0.59	0.59	0.66	0.47	0.65	0.79	0.62	0.67	0.63	0.83	0.93	0.79	0.80	1.08	0.84	1.07	1.35	1.44	1.34	1.39	1.548
P/B Ratio	2.31	2.71	2.99	2.24	2.81	3.47	2.57	2.73	2.38	3.37	3.39	2.73	2.74	3.97	2.96	3.67	4.39	5.33	4.36	4.33	4.812
P/FCF	3.80	3.35	3.70	3.45	4.56	6.69	5.86	4.94	6.11	7.62	8.94	10.00	8.06	11.69	8.93	9.15	11.54	15.28	11.74	14.53	14.529
P/OCF	3.48	3.08	3.38	3.05	4.07	5.84	5.01	4.37	5.16	6.48	7.51	8.03	6.85	9.98	7.83	8.22	10.35	13.28	10.44	12.73	12.729
EV/EBITDA	3.49	2.87	2.90	2.29	3.10	3.96	3.11	3.53	3.43	4.71	5.21	4.64	4.84	6.99	5.27	6.93	8.84	10.19	8.07	8.59	8.590
EV/Revenue	0.59	0.58	0.62	0.47	0.63	0.76	0.57	0.62	0.58	0.78	0.84	0.71	0.72	1.01	0.75	0.97	1.24	1.37	1.21	1.27	1.269
EV/EBIT	4.37	3.38	3.36	2.65	3.60	4.62	3.66	4.17	4.08	5.61	6.23	5.64	5.91	8.62	6.52	8.56	10.91	12.81	9.85	9.95	9.954
EV/FCF	3.79	3.26	3.49	3.49	4.43	6.39	5.33	4.54	5.63	7.10	8.09	9.04	7.23	10.89	7.94	8.29	10.53	14.45	10.60	13.26	13.256
Earnings Yield	16.8%	21.9%	21.1%	28.7%	20.4%	16.1%	19.4%	17.4%	18.0%	12.9%	11.3%	12.4%	11.7%	8.3%	10.5%	8.2%	6.5%	6.0%	7.5%	7.4%	7.43%
FCF Yield	26.3%	29.8%	27.1%	29.0%	21.9%	15.0%	17.1%	20.3%	16.4%	13.1%	11.2%	10.0%	12.4%	8.6%	11.2%	10.9%	8.7%	6.5%	8.5%	6.9%	6.88%
PEG Ratio	snapshot only																				0.735
Price/Tangible Book	snapshot only																				4.328
EV/OCF	snapshot only																				11.614
EV/Gross Profit	snapshot only																				3.238
Acquirers Multiple	snapshot only																				11.503
Shareholder Yield	snapshot only																				5.30%
Graham Number	snapshot only																				$365.73

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	1.83	1.98	1.79	2.04	1.85	2.41	2.10	2.46	2.22	2.67	2.40	3.14	2.38	2.84	2.41	2.68	2.19	2.65	2.37	3.03	3.034
Quick Ratio	0.66	0.86	0.75	0.78	0.64	1.11	0.92	1.17	0.86	1.35	1.17	1.62	1.02	1.43	1.13	1.41	1.00	1.31	1.20	1.58	1.582
Debt/Equity	0.39	0.42	0.40	0.42	0.37	0.35	0.33	0.32	0.31	0.33	0.30	0.29	0.28	0.31	0.30	0.29	0.27	0.31	0.27	0.22	0.215
Net Debt/Equity	-0.01	-0.07	-0.17	0.02	-0.08	-0.15	-0.23	-0.22	-0.19	-0.23	-0.32	-0.26	-0.28	-0.27	-0.33	-0.34	-0.38	-0.29	-0.43	-0.38	-0.379
Debt/Assets	0.16	0.19	0.17	0.19	0.16	0.17	0.15	0.16	0.14	0.16	0.14	0.15	0.13	0.16	0.14	0.15	0.13	0.16	0.13	0.12	0.122
Debt/EBITDA	0.59	0.46	0.41	0.42	0.43	0.42	0.44	0.45	0.48	0.50	0.51	0.54	0.56	0.59	0.60	0.60	0.59	0.63	0.56	0.47	0.469
Net Debt/EBITDA	-0.01	-0.08	-0.17	0.03	-0.09	-0.18	-0.31	-0.31	-0.29	-0.35	-0.54	-0.49	-0.55	-0.51	-0.65	-0.72	-0.85	-0.59	-0.87	-0.82	-0.825
Interest Coverage	18.29	25.96	29.82	29.86	32.68	30.51	39.47	57.30	89.14	1888.79	3359.59	—	—	—	—	324.43	326.51	304.22	351.52	311.59	311.593
Equity Multiplier	2.39	2.24	2.42	2.22	2.36	2.08	2.23	2.05	2.15	2.03	2.10	1.88	2.11	1.97	2.10	1.92	2.10	1.97	2.04	1.77	1.768
Cash Ratio	snapshot only																				1.427
Debt Service Coverage	snapshot only																				361.074
Cash to Debt	snapshot only																				2.760
FCF to Debt	snapshot only																				1.383
Defensive Interval	snapshot only																				258.8 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	1.73	2.09	1.93	2.10	1.86	2.13	1.88	2.06	1.79	2.03	1.78	1.88	1.67	1.89	1.67	1.79	1.57	1.87	1.64	1.78	1.775
Inventory Turnover	2.33	3.46	2.87	3.34	2.47	3.62	2.89	3.38	2.45	3.64	2.86	3.33	2.39	3.46	2.74	3.31	2.38	3.41	2.76	3.21	3.207
Receivables Turnover	213.97	173.25	213.06	195.54	202.68	144.66	154.88	144.58	140.53	117.01	126.19	108.73	112.42	113.38	123.64	112.89	124.26	137.60	126.98	135.22	135.217
Payables Turnover	3.10	6.28	3.43	4.36	3.04	6.54	3.55	4.76	3.24	7.00	3.75	5.05	3.30	6.74	3.75	5.22	3.33	5.90	3.84	5.16	5.158
DSO	2	2	2	2	2	3	2	3	3	3	3	3	3	3	3	3	3	3	3	3	2.7 days
DIO	157	106	127	109	148	101	126	108	149	100	128	110	153	106	133	110	153	107	132	114	113.8 days
DPO	118	58	106	84	120	56	103	77	113	52	97	72	111	54	97	70	109	62	95	71	70.8 days
Cash Conversion Cycle	40	50	23	27	30	48	26	34	39	51	33	41	45	55	39	44	47	48	40	46	45.8 days
Fixed Asset Turnover	snapshot only																				7.373
Operating Cycle	snapshot only																				116.5 days
Cash Velocity	snapshot only																				5.234
Capital Intensity	snapshot only																				0.568

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	27.3%	49.4%	39.0%	23.1%	14.8%	5.6%	0.8%	0.3%	-1.6%	-1.7%	-1.9%	-2.8%	-2.6%	-4.1%	-3.9%	-2.4%	-1.1%	-0.4%	0.6%	0.2%	0.21%
Net Income	9.6%	13.0%	2.8%	1.1%	51.9%	3.4%	-11.9%	-13.2%	-15.8%	-17.1%	-14.8%	-18.5%	-19.0%	-19.7%	-19.5%	-12.8%	-7.7%	-3.9%	13.9%	18.5%	18.51%
EPS	10.5%	14.7%	3.6%	1.5%	78.6%	16.7%	-4.9%	-7.4%	-12.1%	-12.5%	-10.7%	-17.2%	-17.6%	-18.2%	-17.3%	-9.9%	-4.8%	-2.0%	15.3%	19.3%	19.27%
FCF	3.9%	5.1%	1.0%	-3.2%	4.0%	-29.4%	-39.7%	0.2%	-28.6%	-9.4%	-3.8%	-43.7%	-5.5%	-18.8%	-13.4%	45.0%	16.4%	1.8%	21.9%	-18.0%	-18.02%
EBITDA	9.0%	10.8%	1.8%	82.4%	37.2%	0.3%	-14.0%	-15.5%	-18.1%	-15.4%	-12.6%	-14.8%	-13.9%	-16.1%	-16.0%	-10.9%	-7.3%	-7.3%	6.2%	5.8%	5.75%
Op. Income	7.6%	14.5%	2.8%	1.0%	42.1%	0.8%	-15.1%	-16.6%	-20.0%	-17.9%	-15.8%	-19.5%	-18.6%	-20.0%	-19.5%	-12.6%	-8.0%	-7.0%	-3.4%	1.7%	1.75%
OCF Growth	snapshot only																				-15.92%
Asset Growth	snapshot only																				1.78%
Equity Growth	snapshot only																				10.50%
Debt Growth	snapshot only																				-17.12%
Shares Change	snapshot only																				-0.64%
Dividend Growth	snapshot only																				18.34%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	-2.5%	0.6%	2.0%	2.3%	2.8%	3.3%	7.1%	10.5%	12.9%	15.7%	11.2%	6.3%	3.2%	-0.2%	-1.7%	-1.7%	-1.8%	-2.1%	-1.8%	-1.7%	-1.70%
Revenue 5Y	-1.5%	0.6%	1.8%	1.9%	2.1%	1.7%	1.5%	1.3%	1.0%	1.1%	1.0%	0.9%	0.8%	0.8%	3.0%	5.0%	6.7%	8.2%	5.9%	3.2%	3.25%
EPS 3Y	50.4%	90.9%	1.0%	1.2%	1.2%	1.3%	—	—	—	—	57.2%	24.6%	8.9%	-5.8%	-11.1%	-11.6%	-11.7%	-11.1%	-5.2%	-3.8%	-3.82%
EPS 5Y	39.3%	54.3%	59.4%	64.7%	66.9%	46.2%	42.3%	40.3%	39.8%	48.0%	47.2%	51.5%	49.9%	52.6%	—	—	—	—	29.9%	15.8%	15.79%
Net Income 3Y	35.8%	71.8%	78.4%	92.7%	93.0%	1.0%	—	—	—	—	42.4%	14.3%	1.2%	-11.7%	-15.5%	-14.9%	-14.3%	-13.8%	-7.9%	-5.6%	-5.57%
Net Income 5Y	25.4%	38.5%	43.3%	48.6%	50.2%	32.1%	29.0%	26.5%	26.2%	34.1%	33.7%	38.3%	37.4%	39.8%	—	—	—	—	21.5%	9.0%	9.03%
EBITDA 3Y	26.4%	39.9%	46.2%	51.4%	50.9%	48.8%	1.5%	1.3%	1.2%	1.2%	28.8%	9.5%	-1.1%	-10.7%	-14.2%	-13.7%	-13.2%	-13.0%	-8.0%	-7.1%	-7.05%
EBITDA 5Y	10.8%	18.6%	21.7%	23.1%	23.8%	21.0%	19.9%	18.1%	17.8%	18.3%	18.6%	20.1%	19.4%	18.5%	61.6%	54.3%	55.2%	50.9%	13.8%	4.4%	4.36%
Gross Profit 3Y	3.7%	9.2%	11.9%	12.9%	13.0%	12.7%	20.9%	23.5%	25.7%	27.7%	16.0%	8.4%	3.1%	-2.4%	-4.9%	-5.5%	-5.8%	-5.9%	-5.4%	-3.9%	-3.92%
Gross Profit 5Y	1.9%	5.0%	6.6%	7.0%	7.2%	6.3%	5.8%	5.3%	5.0%	5.2%	5.3%	5.4%	5.1%	4.9%	9.6%	10.9%	12.3%	13.0%	6.6%	3.4%	3.45%
Op. Income 3Y	44.3%	60.9%	69.9%	82.7%	82.6%	88.8%	—	—	—	—	40.0%	11.1%	-2.6%	-12.8%	-16.8%	-16.3%	-15.7%	-15.1%	-13.1%	-10.6%	-10.57%
Op. Income 5Y	18.8%	27.9%	32.1%	35.5%	36.8%	32.4%	31.0%	27.9%	27.8%	28.1%	28.5%	32.5%	31.7%	34.6%	—	—	—	—	16.4%	4.0%	4.02%
FCF 3Y	85.2%	72.1%	71.3%	50.8%	63.5%	46.8%	94.3%	—	53.7%	57.4%	5.3%	-18.3%	-11.1%	-19.6%	-20.5%	-6.5%	-7.7%	-9.2%	0.6%	-12.5%	-12.54%
FCF 5Y	19.2%	23.3%	21.7%	23.8%	26.3%	41.9%	46.1%	61.4%	36.3%	26.7%	23.9%	14.1%	24.1%	18.4%	43.7%	—	31.9%	26.4%	4.3%	-8.3%	-8.29%
OCF 3Y	53.4%	51.5%	54.9%	43.1%	51.3%	37.5%	61.4%	1.3%	44.2%	51.7%	8.3%	-13.9%	-8.9%	-17.6%	-19.4%	-7.0%	-7.9%	-9.0%	-0.7%	-12.3%	-12.25%
OCF 5Y	16.1%	19.8%	18.2%	18.7%	20.0%	28.2%	28.5%	35.1%	23.7%	19.2%	18.6%	12.7%	19.6%	14.4%	27.9%	57.3%	25.4%	23.1%	4.9%	-7.0%	-7.01%
Assets 3Y	-2.1%	-1.8%	-1.1%	-2.8%	-0.1%	-1.0%	3.9%	4.4%	5.6%	3.7%	3.9%	2.7%	3.4%	2.9%	2.2%	4.6%	4.3%	1.7%	3.3%	2.2%	2.21%
Assets 5Y	-2.2%	-3.5%	-2.3%	-3.0%	-1.7%	-2.0%	-0.2%	-0.4%	-0.4%	0.1%	0.8%	0.8%	1.7%	0.6%	3.2%	3.6%	5.4%	2.5%	3.4%	2.1%	2.08%
Equity 3Y	-1.3%	-4.7%	-4.5%	-4.2%	-0.1%	-0.5%	6.4%	7.6%	9.5%	5.6%	6.8%	6.6%	7.9%	7.4%	7.1%	9.8%	8.3%	3.6%	6.4%	7.4%	7.45%
Book Value 3Y	9.3%	5.9%	7.7%	8.6%	13.3%	12.3%	18.4%	20.6%	21.4%	16.9%	17.9%	16.3%	16.2%	14.5%	12.6%	14.0%	11.7%	6.8%	9.5%	9.4%	9.43%
Dividend 3Y	7.2%	2.1%	2.2%	2.2%	2.2%	8.5%	6.8%	7.6%	6.3%	19.2%	19.0%	17.7%	16.3%	14.0%	12.3%	10.9%	10.0%	8.7%	8.6%	7.5%	7.50%

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.30	0.08	0.01	0.00	0.02	0.02	0.09	0.15	0.14	0.14	0.16	0.22	0.29	0.30	0.41	0.48	0.51	0.50	0.47	0.39	0.392
Earnings Stability	0.11	0.18	0.30	0.43	0.51	0.47	0.54	0.59	0.61	0.59	0.62	0.61	0.55	0.41	0.40	0.33	0.25	0.12	0.03	0.00	0.000
Margin Stability	0.88	0.86	0.85	0.85	0.84	0.84	0.84	0.85	0.85	0.85	0.89	0.89	0.90	0.90	0.85	0.86	0.86	0.88	0.94	0.97	0.965
Rev. Growth Consistency	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.500
Earn. Growth Consistency	0.50	0.50	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.500
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.20	0.20	0.50	0.50	0.50	0.50	0.95	0.95	0.94	0.93	0.94	0.93	0.92	0.92	0.92	0.95	0.97	0.98	0.94	0.93	0.926
Earnings Smoothness	—	—	0.00	0.29	0.59	0.97	0.87	0.86	0.83	0.81	0.84	0.80	0.79	0.78	0.78	0.86	0.92	0.96	0.87	0.83	0.831
ROE Trend	0.37	0.58	0.60	0.54	0.41	0.29	0.10	0.01	-0.05	-0.14	-0.18	-0.22	-0.18	-0.17	-0.13	-0.11	-0.09	-0.06	-0.02	0.00	0.002
Gross Margin Trend	0.09	0.11	0.12	0.10	0.08	0.06	0.02	0.00	-0.01	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02	-0.03	-0.03	-0.01	-0.011
FCF Margin Trend	0.12	0.13	0.11	0.05	0.04	0.01	-0.04	-0.02	-0.05	-0.04	-0.04	-0.06	-0.02	-0.02	-0.01	0.01	0.02	-0.01	0.01	-0.00	-0.002
Sustainable Growth Rate	40.4%	38.5%	42.6%	41.0%	38.9%	40.7%	35.7%	34.2%	29.6%	24.3%	21.3%	17.5%	15.3%	10.3%	8.8%	8.4%	8.4%	4.8%	8.9%	9.7%	9.70%
Internal Growth Rate	20.3%	21.3%	22.1%	23.4%	19.6%	23.3%	18.2%	19.1%	15.2%	13.4%	10.9%	9.8%	7.8%	5.4%	4.4%	4.6%	4.1%	2.5%	4.5%	5.6%	5.56%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.71	1.48	1.40	1.14	1.20	1.06	1.03	1.32	1.08	1.20	1.18	1.00	1.25	1.20	1.22	1.49	1.49	1.25	1.29	1.06	1.057
FCF/OCF	0.92	0.92	0.91	0.88	0.89	0.87	0.86	0.88	0.84	0.85	0.84	0.80	0.85	0.85	0.88	0.90	0.90	0.87	0.89	0.88	0.876
FCF/Net Income	snapshot only																				0.926
OCF/EBITDA	snapshot only																				0.740
CapEx/Revenue	1.4%	1.6%	1.7%	1.8%	1.7%	1.7%	1.8%	1.8%	1.9%	1.9%	2.0%	1.9%	1.8%	1.6%	1.3%	1.3%	1.3%	1.4%	1.4%	1.4%	1.35%
CapEx/Depreciation	snapshot only																				0.669
Accruals Ratio	-0.12	-0.13	-0.11	-0.04	-0.05	-0.02	-0.01	-0.08	-0.02	-0.04	-0.03	-0.00	-0.04	-0.03	-0.03	-0.08	-0.07	-0.04	-0.05	-0.01	-0.010
Sloan Accruals	snapshot only																				0.014
Cash Flow Adequacy	snapshot only																				1.253
Earnings Quality Score	snapshot only																				1.000

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.4%	7.8%	6.8%	9.4%	6.8%	4.9%	6.3%	5.8%	6.3%	5.9%	5.3%	6.4%	6.3%	5.8%	7.5%	5.9%	4.6%	5.1%	5.5%	5.3%	4.77%
Dividend/Share	$0.65	$15.82	$16.66	$17.41	$17.93	$15.87	$15.93	$16.42	$16.51	$20.90	$20.90	$20.94	$21.16	$26.02	$26.18	$26.34	$26.50	$31.08	$31.12	$31.17	$31.20
Payout Ratio	2.1%	35.4%	32.0%	32.8%	33.2%	30.4%	32.2%	33.4%	34.8%	45.8%	47.3%	51.5%	54.1%	69.7%	71.7%	71.8%	71.2%	85.0%	73.9%	71.3%	71.28%
FCF Payout Ratio	1.4%	26.0%	25.0%	32.5%	30.9%	32.8%	36.7%	28.7%	38.2%	45.1%	47.7%	64.0%	51.0%	67.9%	67.1%	53.7%	53.1%	78.2%	64.6%	77.0%	76.98%
Total Payout Ratio	69.6%	98.6%	1.0%	1.2%	96.8%	81.2%	74.3%	64.0%	68.6%	83.9%	72.1%	61.2%	73.7%	90.1%	1.1%	1.1%	92.5%	1.0%	75.4%	71.3%	71.30%
Div. Increase Streak	0	1	1	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1
Chowder Number	-0.09	20.92	21.60	22.01	22.57	-0.06	-0.05	-0.06	-0.06	0.31	0.31	0.32	0.32	0.28	0.29	0.28	0.26	0.22	0.23	0.23	0.229
Buyback Yield	11.3%	13.9%	15.3%	24.7%	13.0%	8.2%	8.2%	5.3%	6.1%	4.9%	2.8%	1.2%	2.3%	1.7%	4.0%	3.2%	1.4%	1.1%	0.1%	0.0%	0.00%
Net Buyback Yield	11.3%	13.9%	15.3%	24.7%	13.0%	8.2%	8.2%	5.3%	6.1%	4.9%	2.8%	1.2%	2.3%	1.7%	4.0%	3.2%	1.4%	1.1%	0.1%	0.0%	0.00%
Total Shareholder Return	11.7%	21.6%	22.0%	34.1%	19.8%	13.1%	14.4%	11.1%	12.4%	10.8%	8.1%	7.6%	8.6%	7.5%	11.5%	9.1%	6.0%	6.3%	5.6%	5.3%	5.30%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.75	0.79	0.79	0.79	0.79	0.80	0.80	0.80	0.80	0.81	0.81	0.81	0.81	0.81	0.81	0.82	0.82	0.82	0.81	0.81	0.811
Interest Burden (EBT/EBIT)	0.98	0.96	0.95	0.95	0.96	0.97	0.97	0.98	0.99	0.96	0.96	0.96	0.95	0.95	0.94	0.95	0.95	0.99	1.00	1.00	1.000
EBIT Margin	0.14	0.17	0.18	0.18	0.17	0.16	0.15	0.15	0.14	0.14	0.14	0.13	0.12	0.12	0.11	0.11	0.11	0.11	0.12	0.13	0.127
Asset Turnover	1.73	2.09	1.93	2.10	1.86	2.13	1.88	2.06	1.79	2.03	1.78	1.88	1.67	1.89	1.67	1.79	1.57	1.87	1.64	1.78	1.775
Equity Multiplier	2.39	2.19	2.35	2.16	2.37	2.16	2.32	2.13	2.25	2.06	2.16	1.96	2.13	2.00	2.10	1.90	2.10	1.97	2.07	1.84	1.840

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$30.25	$44.68	$52.06	$53.06	$54.01	$52.14	$49.52	$49.16	$47.48	$45.61	$44.20	$40.68	$39.11	$37.33	$36.53	$36.67	$37.23	$36.58	$42.14	$43.73	$43.73
Book Value/Share	$77.79	$75.19	$82.41	$82.41	$94.11	$93.49	$98.98	$103.73	$110.74	$104.76	$115.53	$120.06	$121.95	$112.97	$117.59	$122.24	$131.10	$114.04	$129.85	$135.94	$135.94
Tangible Book/Share	$77.79	$75.19	$82.41	$82.41	$94.11	$93.49	$98.98	$103.73	$110.74	$104.76	$115.53	$120.06	$121.95	$112.97	$117.59	$122.24	$131.10	$114.04	$129.85	$135.94	$135.94
Revenue/Share	$302.61	$343.23	$376.52	$393.90	$408.60	$409.14	$409.75	$421.53	$419.98	$424.35	$421.03	$415.85	$415.99	$414.48	$415.47	$419.47	$424.72	$420.73	$423.40	$423.04	$423.04
FCF/Share	$47.39	$60.76	$66.75	$53.60	$57.95	$48.44	$43.46	$57.30	$43.17	$46.34	$43.82	$32.74	$41.52	$38.34	$39.00	$49.08	$49.87	$39.76	$48.16	$40.49	$40.49
OCF/Share	$51.77	$66.17	$73.01	$60.67	$64.93	$55.46	$50.82	$64.76	$51.11	$54.54	$52.19	$40.76	$48.81	$44.91	$44.45	$54.62	$55.59	$45.75	$54.17	$46.22	$46.22
Cash/Share	$30.82	$37.14	$46.98	$32.24	$42.73	$46.74	$55.67	$56.10	$54.54	$59.03	$71.78	$65.94	$68.90	$65.63	$73.35	$77.19	$85.54	$68.78	$90.86	$80.82	$80.82
EBITDA/Share	$51.38	$69.07	$80.20	$81.70	$82.87	$78.19	$74.42	$73.66	$70.87	$69.83	$68.11	$63.73	$62.09	$59.69	$58.78	$58.72	$59.41	$56.38	$63.26	$62.49	$62.49
Debt/Share	$30.18	$31.54	$33.02	$34.29	$35.25	$32.47	$32.59	$33.48	$33.96	$34.84	$34.71	$34.53	$34.63	$34.93	$35.06	$35.10	$35.17	$35.74	$35.60	$29.28	$29.28
Net Debt/Share	$-0.64	$-5.60	$-13.96	$2.06	$-7.48	$-14.27	$-23.08	$-22.62	$-20.58	$-24.19	$-37.07	$-31.42	$-34.27	$-30.70	$-38.29	$-42.08	$-50.37	$-33.04	$-55.26	$-51.54	$-51.54

Per Employee

Metric	Q3'21	Current
Employee Count	snapshot only	29,100
Revenue/Employee	snapshot only	$226783.51
Income/Employee	snapshot only	$23443.30
EBITDA/Employee	snapshot only	$33501.72
FCF/Employee	snapshot only	$21708.49
Assets/Employee	snapshot only	$128862.54
Market Cap/Employee	snapshot only	$315398.76

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	8.939
Altman Z-Prime	snapshot only																				16.350
Piotroski F-Score	9	8	8	6	8	8	6	6	6	6	7	6	6	6	6	5	5	4	6	8	8
Beneish M-Score	-3.06	-3.62	-3.53	-3.18	-3.33	-2.10	-1.59	-2.94	-2.11	-2.54	-2.74	-1.74	-2.50	-2.68	-2.45	-3.20	-2.91	-2.77	-2.71	-2.39	-2.386
Ohlson O-Score	snapshot only																				-9.618
ROIC (Greenblatt)	snapshot only																				31.24%
Net-Net WC	snapshot only																				$67.44
EVA	snapshot only																				$458310268.73

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AA+
Credit Score	95.43	96.46	97.33	97.40	97.29	97.14	97.15	97.20	97.05	97.13	97.05	95.08	95.15	93.99	93.72	96.32	97.10	96.32	96.41	94.06	94.063
Credit Grade	snapshot only																				2
Credit Trend	snapshot only																				-2.253
Implied Spread (bps)	snapshot only																				65.000
Industry Credit Rank	snapshot only																				80
Sector Credit Rank	snapshot only																				96

DDS NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet